Annexon Biosciences is a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases.
Annexon Biosciences is seeking a Vice President, Clinical Development-Neuroscience to lead the clinical strategy and execution of neurodegeneration and neuro-immunologic diseases programs. The ideal candidate will bring strategic vision, proven expertise in pharmaceutical development, and the ability to manage complex programs in a fast-paced environment.
Annexon Biosciences is a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases.
Neurocrine Biosciences